Equitable Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Equitable Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Buy	67,949 +43,798	+181%	+$5.92M	0.06%	275
2026 Q1	$2.95M	Buy	24,151 +2,132	+10%	+$266K	0.02%	606
2025 Q4	$2.68M	Buy	22,019 +3,992	+22%	+$458K	0.02%	544
2025 Q3	$1.81M	Sell	18,027 -4,672	-21%	-$421K	0.01%	654
2025 Q2	$1.88M	Sell	22,699 -700	-3%	-$55.8K	0.02%	592
2025 Q1	$1.9M	Buy	23,399 +30	+0.1%	+$2.68K	0.02%	524
2024 Q4	$2.1M	Buy	23,369 +1,215	+5%	+$118K	0.02%	472
2024 Q3	$2.19M	Sell	22,154 -6,947	-24%	-$683K	0.02%	467
2024 Q2	$2.7M	Buy	29,101 +4,819	+20%	+$432K	0.03%	390
2024 Q1	$2.3M	Buy	24,282 +4,573	+23%	+$424K	0.03%	411
2023 Q4	$1.76M	Sell	19,709 -10,152	-34%	-$754K	0.02%	445
2023 Q3	$2.18M	Sell	29,861 -964	-3%	-$77K	0.03%	342
2023 Q2	$2.56M	Sell	30,825 -3,961	-11%	-$331K	0.04%	296
2023 Q1	$2.65M	Sell	34,786 -3,783	-10%	-$314K	0.04%	276
2022 Q4	$3.2M	Buy	38,569 +7,758	+25%	+$628K	0.06%	228
2022 Q3	$2.44M	Buy	30,811 +3,108	+11%	+$262K	0.05%	230
2022 Q2	$2.06M	Buy	27,703 +7,523	+37%	+$565K	0.04%	262
2022 Q1	$1.81M	Buy	20,180 +875	+5%	+$80.8K	0.03%	300
2021 Q4	$2.16M	Sell	19,305 -7,753	-29%	-$935K	0.03%	267
2021 Q3	$3.4M	Buy	27,058 +2,920	+12%	+$376K	0.06%	195
2021 Q2	$3.27M	Buy	24,138 +1,549	+7%	+$204K	0.06%	190
2021 Q1	$3.06M	Sell	22,589 -18,733	-45%	-$2.8M	0.06%	179
2020 Q4	$5.82M	Sell	41,322 -1,333	-3%	-$171K	0.13%	113
2020 Q3	$4.75M	Buy	42,655 +3,154	+8%	+$354K	0.12%	115
2020 Q2	$4.42M	Buy	39,501 +3,599	+10%	+$354K	0.13%	114
2020 Q1	$2.78M	Buy	35,902 +30,996	+632%	+$2.74M	0.1%	130
2019 Q4	$467K	Buy	+4,906	New	+$424K	0.01%	414

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Equitable Holdings's XBI Position: Q2 2026 in Review

Equitable Holdings increased its State Street SPDR S&P Biotech ETF (XBI) stake by 181% in Q2 2026, buying an estimated $5.92M and bringing the position to 67,949 shares worth $10.8M. The position accounts for 0.06% of the portfolio, ranked #275.

Equitable Holdings first reported a position in XBI in Q4 2019 and has held it in 27 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Equitable Holdings held 67,949 shares of State Street SPDR S&P Biotech ETF worth $10.8M as of Q2 2026.
Equitable Holdings bought 43,798 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $5.92M.
State Street SPDR S&P Biotech ETF made up 0.06% of Equitable Holdings's portfolio in Q2 2026, its #275 holding.
Equitable Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 27 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.